 |
市場調査レポート
商品コード
1448334
尿路感染症検査の世界市場規模、シェア、成長分析：感染タイプ別、検査タイプ別、エンドユーザー別、検査キット別 - 業界予測（2024年～2031年）Global Urinary Tract Infection Testing Market Size, Share, Growth Analysis, By Infection Type, By Test Type, By End-user, By Test Kit - Industry Forecast 2024-2031 |
||||||
| 尿路感染症検査の世界市場規模、シェア、成長分析：感染タイプ別、検査タイプ別、エンドユーザー別、検査キット別 - 業界予測（2024年～2031年） |
|
出版日: 2024年03月03日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
尿路感染症検査の世界市場規模は2022年に87億米ドルと評価され、2023年の90億6,000万米ドルから2031年には124億9,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは4.1%で推移する見通しです。
尿路感染症（UTI）検査の世界市場は、診断技術の向上とUTIに対する意識の高まりにより発展しています。尿路感染症は一般的な細菌感染症で、主に世界中の女性が罹患します。尿路感染症検査市場を牽引する要因としては、尿路感染症患者数の増加、ヘルスケアへの支出の増加、これらの感染症にかかりやすい高齢者人口の増加などが挙げられます。技術の進歩により、ポイントオブケア検査や非侵襲的方法など、正確で効率的な診断ツールが開発され、UTIの早期発見と治療が向上しています。また、個別化医療や予防医療への注力により、医療提供者は高度な診断ソリューションを使用するようになり、UTI検査製品の需要が増加しています。しかし、一部の検査法の精度や代替治療法の有無に関する課題は、市場の成長をやや鈍らせる可能性があります。ヘルスケア部門が引き続き感染管理を優先していることから、UTI検査市場は今後も安定した成長が見込まれます。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
尿路感染症検査の世界市場：感染タイプ別
- 市場概要
- 尿道炎
- 膀胱炎
- 腎盂腎炎
尿路感染症検査の世界市場：検査タイプ別
- 市場概要
- 尿検査
- 尿培養
- 感受性試験
尿路感染症検査の世界市場：エンドユーザー別
- 市場概要
- 病院
- 診断研究所
- 研究機関
尿路感染症検査の世界市場：検査キット別
- 市場概要
- 家庭用検査キット
- 臨床検査キット
尿路感染症検査の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- QIAGEN（Germany）
- Accelerate Diagnostics, Inc.（US）
- Bio-Rad Laboratories, Inc.（US）
- F. Hoffmann-La Roche Ltd.（Switzerland）
- Danaher Corporation（US）
- Siemens Healthcare GmbH（Germany）
- Randox Laboratories Ltd.（UK）
- Thermo Fisher Scientific, Inc.（US）
- bioMerieux SA（France）
- T2 Biosystems, Inc.（US）
- Beckman Coulter, Inc.（US）
- Becton, Dickinson and Company（US）
- Sysmex Corporation（Japan）
- Cepheid（US）
- GenMark Diagnostics, Inc.（US）
- Hologic, Inc.（US）
- Ortho Clinical Diagnostics（US）
- Luminex Corporation（US）
- Bruker Corporation（US）
- Trinity Biotech plc（Ireland）
Global Urinary Tract Infection Testing Market size was valued at USD 8.7 billion in 2022 and is poised to grow from USD 9.06 billion in 2023 to USD 12.49 billion by 2031, growing at a CAGR of 4.1% in the forecast period (2024- 2031).
The global market for testing urinary tract infections (UTIs) is evolving due to improvements in diagnostic technologies and increased awareness about UTIs. UTIs are common bacterial infections that mainly affect women worldwide. Factors driving the UTI testing market include the rising number of UTI cases, more spending on healthcare, and a growing elderly population prone to these infections. Technological advancements have led to the creation of accurate and efficient diagnostic tools, such as point-of-care tests and non-invasive methods, improving early detection and treatment of UTIs. Also, the focus on personalized and preventive healthcare has led to healthcare providers using advanced diagnostic solutions, increasing the demand for UTI testing products. However, challenges related to the accuracy of some testing methods and the availability of alternative treatments may slightly slow market growth. As the healthcare sector continues to prioritize infection management, the UTI testing market is expected to grow steadily in the future.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinary Tract Infection Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Urinary Tract Infection Testing Market Segmental Analysis
The global urinary tract infection testing market is segmented on the basis of Infection Type, Test type, end-user, Test kit and region. By Infection type, the market is segmented into Urethritis, Cystitis, Pyelonephritis. By Test type, the market is segmented into Urinalysis , Urine Cultures, Susceptibility Testing. By End-User, the market is segmented into Hospitals, Diagnostic Laboratories, Research Institutes. By Test kit, the market is segmented into Home Test Kits, Laboratory Test Kits. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Urinary Tract Infection Testing Market
The global market for urinary tract infections (UTIs) is greatly affected by the increasing prevalence of antibiotic-resistant UTIs. The misuse and overuse of antibiotics have caused bacteria to become resistant to traditional treatments, making UTI management more complex. This urgent issue has created a demand for precise diagnostic tools like urine cultures and susceptibility testing. These tools help healthcare providers identify effective treatment options tailored to specific bacterial strains. Furthermore, the need to address antibiotic resistance has led to investments in research and development for new therapies. This focus on innovation is shaping the market toward solutions that combat resistant UTIs while promoting responsible antibiotic use.
Restraints in the Global Urinary Tract Infection Testing Market
Antibiotic resistance is a major obstacle in the global urinary tract infection (UTI) market. Overusing and misusing antibiotics have caused drug-resistant bacteria to emerge, making commonly used antibiotics less effective in treating UTIs. This issue makes treatment decisions more complicated and can lead to longer infections, higher healthcare expenses, and potential complications. Healthcare providers must carefully balance effective treatment with responsible antibiotic use to address this growing problem. This highlights the need for alternative treatment methods and diagnostic strategies in the UTI market.
Market Trends of the Global Urinary Tract Infection Testing Market
A notable trend in the global urinary tract infection (UTI) market is the increasing use of Point-of-Care (POC) testing methods. These tests provide fast results and convenient on-the-spot diagnostics, eliminating the need for centralized laboratory facilities and reducing turnaround times. This trend meets the demand for quick and accurate UTI diagnosis, especially in primary care settings. The adoption of POC testing technologies enables healthcare professionals to make timely treatment decisions, improve patient outcomes, and optimize resource allocation. As technology advances improve the accuracy and efficiency of POC tests, their widespread use is changing the landscape of UTI diagnostics.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Urinary Tract Infection Testing Market by Infection Type
- Market Overview
- Urethritis
- Cystitis
- and Pyelonephritis
Global Urinary Tract Infection Testing Market by Test Type
- Market Overview
- Urinalysis
- Urine Cultures
- Susceptibility Testing
Global Urinary Tract Infection Testing Market by End-user
- Market Overview
- Hospitals
- Diagnostic Laboratories
- Research Institutes
Global Urinary Tract Infection Testing Market by Test Kit
- Market Overview
- Home Test Kits
- Laboratory Test Kits
Global Urinary Tract Infection Testing Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- QIAGEN (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Accelerate Diagnostics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthcare GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Randox Laboratories Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- T2 Biosystems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beckman Coulter, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cepheid (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenMark Diagnostics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ortho Clinical Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Luminex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bruker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Trinity Biotech plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
